GE HealthCare Technologies Inc.
GEHC · Nasdaq · United States · Health Care · HC Equipment & Services
- Coverage
- FY2020–FY2025
- History
- 6 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- December
- Last updated
- Feb 2026
Headline figures
GE HealthCare Technologies Inc. at a glance
In FY2025, GE HealthCare Technologies Inc. reported revenue of USD 20,625 mn, EBITDA of USD 7,064 mn, EBITDA margin of 34.2%.
| USD mn | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 19,672 | 20,625 | |||
| EBITDA | 6,807 | 7,064 | |||
| EBITDA margin | 34.6% | 34.2% | |||
| Free cash flow | 1,550 | 1,505 | |||
| ROIC | 33.0% | 31.2% |
The full 6-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas